These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 9764797)

  • 21. The effects of antiretroviral protease inhibitors on serum lipid levels in HIV-infected patients.
    Chang ES; Tetreault DD; Liu YT; Beall GN
    J Am Diet Assoc; 2001 Jun; 101(6):687-9. PubMed ID: 11424549
    [No Abstract]   [Full Text] [Related]  

  • 22. Mutational patterns and correlated amino acid substitutions in the HIV-1 protease after virological failure to nelfinavir- and lopinavir/ritonavir-based treatments.
    Garriga C; Pérez-Elías MJ; Delgado R; Ruiz L; Nájera R; Pumarola T; Alonso-Socas Mdel M; García-Bujalance S; Menéndez-Arias L;
    J Med Virol; 2007 Nov; 79(11):1617-28. PubMed ID: 17854027
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ritonavir-fluticasone interaction causing Cushing syndrome in HIV-infected children and adolescents.
    Arrington-Sanders R; Hutton N; Siberry GK
    Pediatr Infect Dis J; 2006 Nov; 25(11):1044-8. PubMed ID: 17072128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The protease inhibitor lopinavir-ritonavir may produce opiate withdrawal in methadone-maintained patients.
    McCance-Katz EF; Rainey PM; Friedland G; Jatlow P
    Clin Infect Dis; 2003 Aug; 37(4):476-82. PubMed ID: 12905130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acanthosis nigricans: a new manifestation of insulin resistance in patients receiving treatment with protease inhibitors.
    Mellor-Pita S; Yebra-Bango M; Alfaro-Martínez J; Suárez E
    Clin Infect Dis; 2002 Mar; 34(5):716-7. PubMed ID: 11823959
    [No Abstract]   [Full Text] [Related]  

  • 26. Dramatic interaction between levothyroxine and lopinavir/ritonavir in a HIV-infected patient.
    Touzot M; Beller CL; Touzot F; Louet AL; Piketty C
    AIDS; 2006 May; 20(8):1210-2. PubMed ID: 16691080
    [No Abstract]   [Full Text] [Related]  

  • 27. The long-term pharmacokinetics and safety of adding low-dose ritonavir to a nelfinavir 1,250 mg twice-daily regimen in HIV-infected patients.
    Justesen US; Hansen IM; Andersen AB; Klitgaard NA; Black FT; Gerstoft J; Mathiesen LR; Pedersen C
    HIV Med; 2005 Sep; 6(5):334-40. PubMed ID: 16156881
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetic interaction between rifampicin and the once-daily combination of saquinavir and low-dose ritonavir in HIV-infected patients with tuberculosis.
    Ribera E; Azuaje C; Lopez RM; Domingo P; Curran A; Feijoo M; Pou L; Sánchez P; Sambeat MA; Colomer J; Lopez-Colomes JL; Crespo M; Falcó V; Ocaña I; Pahissa A
    J Antimicrob Chemother; 2007 Apr; 59(4):690-7. PubMed ID: 17307771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A randomized trial to evaluate lopinavir/ritonavir versus saquinavir/ritonavir in HIV-1-infected patients: the MaxCmin2 trial.
    Dragsted UB; Gerstoft J; Youle M; Fox Z; Losso M; Benetucci J; Jayaweera DT; Rieger A; Bruun JN; Castagna A; Gazzard B; Walmsley S; Hill A; Lundgren JD;
    Antivir Ther; 2005; 10(6):735-43. PubMed ID: 16218173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [New treatment options for HIV-infected patients].
    Wehr A
    Dtsch Med Wochenschr; 2004 May; 129(19):1093. PubMed ID: 15174468
    [No Abstract]   [Full Text] [Related]  

  • 31. Pregnancy outcomes in women with HIV type-1 receiving a lopinavir/ritonavir-containing regimen.
    Azria E; Moutafoff C; Schmitz T; Le Meaux JP; Krivine A; Pannier E; Firtion G; Compagnucci A; Finkielsztejn L; Taulera O; Tsatsaris V; Cabrol D; Launay O
    Antivir Ther; 2009; 14(3):423-32. PubMed ID: 19474476
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ritonavir and renal failure.
    Chugh S; Bird R; Alexander EA
    N Engl J Med; 1997 Jan; 336(2):138. PubMed ID: 8992345
    [No Abstract]   [Full Text] [Related]  

  • 33. Cholesterol levels in HIV-HCV infected patients treated with lopinavir/r: results from the SCOLTA project.
    De Socio GV; Bonfanti P; Ricci E; Orofino G; Madeddu G; Penco G; Gianelli E; Martinelli C; Carradori S; Quirino T; Rizzardini G;
    Biomed Pharmacother; 2008 Jan; 62(1):16-20. PubMed ID: 17851026
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of hepatotoxicity in HIV patients switching at least one protease inhibitor.
    Aceti A; Pasquazzi C; Zechini B; De Bac C;
    Int J STD AIDS; 2005 Feb; 16(2):148-52. PubMed ID: 15825250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is treatment with ritonavir a risk factor for myocardial infarction in HIV-infected patients?
    Eriksson U; Opravil M; Amann FW; Schaffner A
    AIDS; 1998 Oct; 12(15):2079-80. PubMed ID: 9814881
    [No Abstract]   [Full Text] [Related]  

  • 36. Spontaneous bleeding associated with the use of the protease inhibitor ritonavir in a hemophiliac patient with human immunodeficiency virus infection.
    Hagerty SL; Ascher DP
    Pediatr Infect Dis J; 1998 Oct; 17(10):929-30. PubMed ID: 9802643
    [No Abstract]   [Full Text] [Related]  

  • 37. Life-threatening acute generalized exanthematous pustulosis induced by two different protease inhibitors in an HIV-1-infected patient.
    Bourkia M; Charlès L; Lambotte O; Orostegui-Giron L; Goujard C; Ghosn J
    J Antimicrob Chemother; 2011 Sep; 66(9):2188-9. PubMed ID: 21636585
    [No Abstract]   [Full Text] [Related]  

  • 38. Budesonide-induced acute hepatitis in an HIV-positive patient with ritonavir as a co-medication.
    Sagir A; Wettstein M; Oette M; Erhardt A; Häussinger D
    AIDS; 2002 May; 16(8):1191-2. PubMed ID: 12004282
    [No Abstract]   [Full Text] [Related]  

  • 39. Sustained alanine aminotransferase increase during hepatitis A due to concomitant lymphogranuloma venereum infection in an HIV-1 positive patient.
    Chakvetadze C; Bani-Sadr F; Slama L; Pialoux G; Roque-Afonso AM; Dussaix E
    Gastroenterol Clin Biol; 2008; 32(6-7):657-9. PubMed ID: 18554836
    [No Abstract]   [Full Text] [Related]  

  • 40. HIV protease inhibitors and increased bleeding in hemophilia?
    Hélal A
    CMAJ; 1997 Jan; 156(1):90, 94-5. PubMed ID: 9006575
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.